Hidden toll of myasthenia gravis: study probes sexual and bladder problems often overlooked
NCT ID NCT07677852
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study investigates sexual and urinary problems in people with generalized myasthenia gravis, an autoimmune disease that causes muscle weakness. While visible symptoms like droopy eyelids are well-known, issues like sexual dysfunction and bladder problems are often ignored. Researchers will use questionnaires to measure how common these hidden symptoms are and how they affect quality of life. The goal is to help doctors better recognize and address these underreported concerns.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors recognize and address hidden symptoms like sexual and bladder issues in myasthenia gravis, potentially improving patients' quality of life.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change how the disease is managed. The results may not apply to all patients with myasthenia gravis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS (MG) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHP and Myology institute
Paris, 75000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Nice University hospital
Nice, 06000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact